<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39334881</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2218-273X</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>04</Day></PubDate></JournalIssue><Title>Biomolecules</Title><ISOAbbreviation>Biomolecules</ISOAbbreviation></Journal><ArticleTitle>A Nanobody of PEDV S1 Protein: Screening and Expression in <i>Escherichia coli</i>.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1116</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biom14091116</ELocationID><Abstract><AbstractText>Porcine epidemic diarrhea virus (PEDV) has caused significant economic losses to the pig farming industry in various countries for a long time. Currently, there are no highly effective preventive or control measures available. Research into the pathogenic mechanism of PEDV has shown that it primarily causes infection by binding the S protein to the CD13 (APN) receptor on the membrane of porcine intestinal epithelial cells. The S1 region contains three neutralization epitopes and multiple receptor-binding domains, which are closely related to viral antigenicity and ad-sorption invasion. Nanobodies are a type of single-domain antibody that have been discovered in recent years. They can be expressed on a large scale through prokaryotic expression systems, which makes them cost-effective, stable, and less immunogenic. This study used a phage display library of nanobodies against the PEDV S1 protein. After three rounds of selection and enrichment, the DNA sequence of the highly specific nanobody S1Nb1 was successfully obtained. To obtain soluble nanobody S1Nb1, its DNA sequence was inserted into the vector Pcold and a solubility-enhancing SUMO tag was added. The resulting recombinant vector, Pcold-SUMO-S1Nb1, was then transformed into <i>E. coli</i> BL21(DE3) to determine the optimal expression conditions for the nanobody. Following purification using Ni-column affinity chromatography, Western blot analysis confirmed the successful purification of S1Nb1 carrying the solubility-enhancing tag. ELISA results demonstrated a strong affinity between the S1Nb1 nanobody and PEDV S1 protein.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hao</LastName><ForeName>Zhipeng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Xufeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhongtao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Zhihua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>College of Veterinary Medicine, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>WST2019013</GrantID><Agency>Shandong Province "Double-Hundred Talent Plan"</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomolecules</MedlineTA><NlmUniqueID>101596414</NlmUniqueID><ISSNLinking>2218-273X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D061905">Single-Domain Antibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019151">Peptide Library</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D053485" MajorTopicYN="Y">Porcine epidemic diarrhea virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061905" MajorTopicYN="Y">Single-Domain Antibodies</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="Y">Escherichia coli</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013552" MajorTopicYN="N">Swine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019151" MajorTopicYN="N">Peptide Library</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Escherichia coli</Keyword><Keyword MajorTopicYN="N">PEDV</Keyword><Keyword MajorTopicYN="N">nanobodies</Keyword><Keyword MajorTopicYN="N">soluble expression</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39334881</ArticleId><ArticleId IdType="pmc">PMC11430113</ArticleId><ArticleId IdType="doi">10.3390/biom14091116</ArticleId><ArticleId IdType="pii">biom14091116</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pensaert M.B., de Bouck P. A new coronavirus-like particle associated with diarrhea in swine. Arch. Virol. 1978;58:243–247. doi: 10.1007/BF01317606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01317606</ArticleId><ArticleId IdType="pmc">PMC7086830</ArticleId><ArticleId IdType="pubmed">83132</ArticleId></ArticleIdList></Reference><Reference><Citation>Pijpers A., van Nieuwstadt A.P., Terpstra C., Verheijden J.H. Porcine epidemic diarrhoea virus as a cause of persistent diarrhoea in a herd of breeding and finishing pigs. Vet. Rec. 1993;132:129–131. doi: 10.1136/vr.132.6.129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/vr.132.6.129</ArticleId><ArticleId IdType="pubmed">8383370</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung K., Saif L.J., Wang Q. Porcine epidemic diarrhea virus (PEDV): An update on etiology, transmission, pathogenesis, and prevention and control. Virus Res. 2020;286:198045. doi: 10.1016/j.virusres.2020.198045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.198045</ArticleId><ArticleId IdType="pmc">PMC7266596</ArticleId><ArticleId IdType="pubmed">32502552</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C.M., Saif L.J., Marthaler D., Wang Q. Evolution, antigenicity and pathogenicity of global porcine epidemic diarrhea virus strains. Virus Res. 2016;226:20–39. doi: 10.1016/j.virusres.2016.05.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2016.05.023</ArticleId><ArticleId IdType="pmc">PMC7111424</ArticleId><ArticleId IdType="pubmed">27288724</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Li Y., Huang J., Yao Y., Zhao W., Zhang Y., Qing J., Ren J., Yan Z., Wang Z., et al. Isolation and oral immunogenicity assessment of porcine epidemic diarrhea virus NH-TA2020 strain: One of the predominant strains circulating in China from 2017 to 2021. Virol. Sin. 2022;37:646–655. doi: 10.1016/j.virs.2022.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virs.2022.08.002</ArticleId><ArticleId IdType="pmc">PMC9583181</ArticleId><ArticleId IdType="pubmed">35961502</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J., Liu H., Qian Y., Wang Z., Tang Q., Cao W. Study on the transmissible gastroenteritis coronavirus. Agric. Sci. Technol. Shanghai. 1980;2:42–45.</Citation></Reference><Reference><Citation>Xuan H., Xing D.-k., Wang D.-y., Zhu W., Zhao F., Gong H., Fei S. Study on the culture of porcine epidemic diarrhea virus adapted to fetal porcine intestine primary cell monolayer. Chin. J. Vet. Sci. 1984;4:202–208.</Citation></Reference><Reference><Citation>Rosas-Murrieta N.H., Rodriguez-Enriquez A., Herrera-Camacho I., Millan-Perez-Pena L., Santos-Lopez G., Rivera-Benitez J.F. Comparative Review of the State of the Art in Research on the Porcine Epidemic Diarrhea Virus and SARS-CoV-2, Scope of Knowledge between Coronaviruses. Viruses. 2024;16:238. doi: 10.3390/v16020238.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v16020238</ArticleId><ArticleId IdType="pmc">PMC10892376</ArticleId><ArticleId IdType="pubmed">38400014</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Y., Yang Y., Zhao J., Geng N., Liu K., Zhao Y., Wang F., Liu S., Li N., Meng F., et al. Molecular epidemiological survey of porcine epidemic diarrhea in some areas of Shandong and genetic evolutionary analysis of S gene. Front. Vet. Sci. 2022;9:1015717. doi: 10.3389/fvets.2022.1015717.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fvets.2022.1015717</ArticleId><ArticleId IdType="pmc">PMC9562854</ArticleId><ArticleId IdType="pubmed">36246337</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C., Li W., Lucio de Esesarte E., Guo H., van den Elzen P., Aarts E., van den Born E., Rottier P.J.M., Bosch B.J. Cell Attachment Domains of the Porcine Epidemic Diarrhea Virus Spike Protein Are Key Targets of Neutralizing Antibodies. J. Virol. 2017;91:e00273-17. doi: 10.1128/JVI.00273-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00273-17</ArticleId><ArticleId IdType="pmc">PMC5446644</ArticleId><ArticleId IdType="pubmed">28381581</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J., Li Q., Shao C., Ma Y., He H., Jiang S., Zhou Y., Wu Y., Ba S., Shi L., et al. Isolation and characterization of Chinese porcine epidemic diarrhea virus with novel mutations and deletions in the S gene. Vet. Microbiol. 2018;221:81–89. doi: 10.1016/j.vetmic.2018.05.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2018.05.021</ArticleId><ArticleId IdType="pmc">PMC7117340</ArticleId><ArticleId IdType="pubmed">29981713</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosch B.J., van der Zee R., de Haan C.A., Rottier P.J. The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex. J. Virol. 2003;77:8801–8811. doi: 10.1128/JVI.77.16.8801-8811.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.77.16.8801-8811.2003</ArticleId><ArticleId IdType="pmc">PMC167208</ArticleId><ArticleId IdType="pubmed">12885899</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang S.H., Bae J.L., Kang T.J., Kim J., Chung G.H., Lim C.W., Laude H., Yang M.S., Jang Y.S. Identification of the epitope region capable of inducing neutralizing antibodies against the porcine epidemic diarrhea virus. Mol. Cells. 2002;14:295–299. doi: 10.1016/S1016-8478(23)15106-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1016-8478(23)15106-5</ArticleId><ArticleId IdType="pubmed">12442904</ArticleId></ArticleIdList></Reference><Reference><Citation>Godet M., Grosclaude J., Delmas B., Laude H. Major receptor-binding and neutralization determinants are located within the same domain of the transmissible gastroenteritis virus (coronavirus) spike protein. J. Virol. 1994;68:8008–8016. doi: 10.1128/jvi.68.12.8008-8016.1994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.68.12.8008-8016.1994</ArticleId><ArticleId IdType="pmc">PMC237264</ArticleId><ArticleId IdType="pubmed">7525985</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C., Tang J., Ma Y., Liang X., Yang Y., Peng G., Qi Q., Jiang S., Li J., Du L., et al. Receptor usage and cell entry of porcine epidemic diarrhea coronavirus. J. Virol. 2015;89:6121–6125. doi: 10.1128/JVI.00430-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00430-15</ArticleId><ArticleId IdType="pmc">PMC4442452</ArticleId><ArticleId IdType="pubmed">25787280</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Chen Y., Zhou J., Wang X., Ma L., Li J., Yang L., Yuan H., Pang D., Ouyang H. Porcine Epidemic Diarrhea Virus: An Updated Overview of Virus Epidemiology, Virulence Variation Patterns and Virus-Host Interactions. Viruses. 2022;14:2434. doi: 10.3390/v14112434.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14112434</ArticleId><ArticleId IdType="pmc">PMC9695474</ArticleId><ArticleId IdType="pubmed">36366532</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong N., Meng Q., Jiao Y., Wu Y., Zuo Y., Wang H., Sun D., Dong S., Zhai H., Tong W., et al. Identification of a novel B-cell epitope in the spike protein of porcine epidemic diarrhea virus. Virol. J. 2020;17:46. doi: 10.1186/s12985-020-01305-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-020-01305-1</ArticleId><ArticleId IdType="pmc">PMC7119268</ArticleId><ArticleId IdType="pubmed">32245493</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi W., Hao H., Li M., Niu J., Hu Y., Zhao X., Li Q. Expression and Purification of a PEDV-Neutralizing Antibody and Its Functional Verification. Viruses. 2021;13:472. doi: 10.3390/v13030472.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13030472</ArticleId><ArticleId IdType="pmc">PMC7999980</ArticleId><ArticleId IdType="pubmed">33809239</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirato K., Maejima M., Islam M.T., Miyazaki A., Kawase M., Matsuyama S., Taguchi F. Porcine aminopeptidase N is not a cellular receptor of porcine epidemic diarrhea virus, but promotes its infectivity via aminopeptidase activity. J. Gen. Virol. 2016;97:2528–2539. doi: 10.1099/jgv.0.000563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000563</ArticleId><ArticleId IdType="pubmed">27449937</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Luo R., He Q., van Kuppeveld F.J.M., Rottier P.J.M., Bosch B.J. Aminopeptidase N is not required for porcine epidemic diarrhea virus cell entry. Virus Res. 2017;235:6–13. doi: 10.1016/j.virusres.2017.03.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2017.03.018</ArticleId><ArticleId IdType="pmc">PMC7114539</ArticleId><ArticleId IdType="pubmed">28363778</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitworth K.M., Rowland R.R.R., Petrovan V., Sheahan M., Cino-Ozuna A.G., Fang Y., Hesse R., Mileham A., Samuel M.S., Wells K.D., et al. Resistance to coronavirus infection in amino peptidase N-deficient pigs. Transgenic Res. 2019;28:21–32. doi: 10.1007/s11248-018-0100-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11248-018-0100-3</ArticleId><ArticleId IdType="pmc">PMC6353812</ArticleId><ArticleId IdType="pubmed">30315482</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Wu Z., Yang H. Aminopeptidase N Knockout Pigs Are Not Resistant to Porcine Epidemic Diarrhea Virus Infection. Virol. Sin. 2019;34:592–595. doi: 10.1007/s12250-019-00127-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-019-00127-y</ArticleId><ArticleId IdType="pmc">PMC6814656</ArticleId><ArticleId IdType="pubmed">31134585</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamers-Casterman C., Atarhouch T., Muyldermans S., Robinson G., Hamers C., Songa E.B., Bendahman N., Hamers R. Naturally occurring antibodies devoid of light chains. Nature. 1993;363:446–448. doi: 10.1038/363446a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/363446a0</ArticleId><ArticleId IdType="pubmed">8502296</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith G.P. Filamentous fusion phage: Novel expression vectors that display cloned antigens on the virion surface. Science. 1985;228:1315–1317. doi: 10.1126/science.4001944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.4001944</ArticleId><ArticleId IdType="pubmed">4001944</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakravarty R., Goel S., Cai W. Nanobody: The “magic bullet” for molecular imaging? Theranostics. 2014;4:386–398. doi: 10.7150/thno.8006.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.8006</ArticleId><ArticleId IdType="pmc">PMC3936291</ArticleId><ArticleId IdType="pubmed">24578722</ArticleId></ArticleIdList></Reference><Reference><Citation>Muyldermans S. A guide to: Generation and design of nanobodies. FEBS J. 2021;288:2084–2102. doi: 10.1111/febs.15515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.15515</ArticleId><ArticleId IdType="pmc">PMC8048825</ArticleId><ArticleId IdType="pubmed">32780549</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassanzadeh-Ghassabeh G., Devoogdt N., De Pauw P., Vincke C., Muyldermans S. Nanobodies and their potential applications. Nanomedicine. 2013;8:1013–1026. doi: 10.2217/nnm.13.86.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/nnm.13.86</ArticleId><ArticleId IdType="pubmed">23730699</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Heeke G., Allosery K., De Brabandere V., De Smedt T., Detalle L., de Fougerolles A. Nanobodies(R) as inhaled biotherapeutics for lung diseases. Pharmacol. Ther. 2017;169:47–56. doi: 10.1016/j.pharmthera.2016.06.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2016.06.012</ArticleId><ArticleId IdType="pubmed">27373507</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell L.S., Colwell L.J. Comparative analysis of nanobody sequence and structure data. Proteins. 2018;86:697–706. doi: 10.1002/prot.25497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.25497</ArticleId><ArticleId IdType="pmc">PMC6033041</ArticleId><ArticleId IdType="pubmed">29569425</ArticleId></ArticleIdList></Reference><Reference><Citation>Harmsen M.M., De Haard H.J. Properties, production, and applications of camelid single-domain antibody fragments. Appl. Microbiol. Biotechnol. 2007;77:13–22. doi: 10.1007/s00253-007-1142-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00253-007-1142-2</ArticleId><ArticleId IdType="pmc">PMC2039825</ArticleId><ArticleId IdType="pubmed">17704915</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M., Fan X., Liu J., Hu Y., Huang H. Selection by phage display of nanobodies directed against hypoxia inducible factor-1alpha (HIF-1alpha) Biotechnol. Appl. Biochem. 2015;62:738–745. doi: 10.1002/bab.1340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bab.1340</ArticleId><ArticleId IdType="pubmed">25556956</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang E., Liu Q., Huang G., Liu J., Wei W. Engineering nanobodies for next-generation molecular imaging. Drug Discov. Today. 2022;27:1622–1638. doi: 10.1016/j.drudis.2022.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drudis.2022.03.013</ArticleId><ArticleId IdType="pubmed">35331925</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumoulin M., Conrath K., Van Meirhaeghe A., Meersman F., Heremans K., Frenken L.G., Muyldermans S., Wyns L., Matagne A. Single-domain antibody fragments with high conformational stability. Protein Sci. 2002;11:500–515. doi: 10.1110/ps.34602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1110/ps.34602</ArticleId><ArticleId IdType="pmc">PMC2373476</ArticleId><ArticleId IdType="pubmed">11847273</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur H. Stability testing in monoclonal antibodies. Crit. Rev. Biotechnol. 2021;41:692–714. doi: 10.1080/07388551.2021.1874281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07388551.2021.1874281</ArticleId><ArticleId IdType="pubmed">33596751</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldman E.R., Liu J.L., Zabetakis D., Anderson G.P. Enhancing Stability of Camelid and Shark Single Domain Antibodies: An Overview. Front. Immunol. 2017;8:865. doi: 10.3389/fimmu.2017.00865.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00865</ArticleId><ArticleId IdType="pmc">PMC5524736</ArticleId><ArticleId IdType="pubmed">28791022</ArticleId></ArticleIdList></Reference><Reference><Citation>Peyron I., Kizlik-Masson C., Dubois M.D., Atsou S., Ferriere S., Denis C.V., Lenting P.J., Casari C., Christophe O.D. Camelid-derived single-chain antibodies in hemostasis: Mechanistic, diagnostic, and therapeutic applications. Res. Pract. Thromb. Haemost. 2020;4:1087–1110. doi: 10.1002/rth2.12420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rth2.12420</ArticleId><ArticleId IdType="pmc">PMC7590285</ArticleId><ArticleId IdType="pubmed">33134775</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvador J.P., Vilaplana L., Marco M.P. Nanobody: Outstanding features for diagnostic and therapeutic applications. Anal. Bioanal. Chem. 2019;411:1703–1713. doi: 10.1007/s00216-019-01633-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00216-019-01633-4</ArticleId><ArticleId IdType="pubmed">30734854</ArticleId></ArticleIdList></Reference><Reference><Citation>Bates A., Power C.A. David vs. Goliath: The Structure, Function, and Clinical Prospects of Antibody Fragments. Antibodies. 2019;8:28. doi: 10.3390/antib8020028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antib8020028</ArticleId><ArticleId IdType="pmc">PMC6640713</ArticleId><ArticleId IdType="pubmed">31544834</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Xiong L., Li Y., Xiong Y., Tu Z., Fu J., Chen B. Anti-idiotypic nanobody as citrinin mimotope from a naive alpaca heavy chain single domain antibody library. Anal. Bioanal. Chem. 2015;407:5333–5341. doi: 10.1007/s00216-015-8693-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00216-015-8693-3</ArticleId><ArticleId IdType="pubmed">25910884</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S., Li L., Yin S., Shang Y., Khan M.U.Z., He X., Yuan L., Gao X., Liu X., Cai J. Single-domain antibodies as promising experimental tools in imaging and isolation of porcine epidemic diarrhea virus. Appl. Microbiol. Biotechnol. 2018;102:8931–8942. doi: 10.1007/s00253-018-9324-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00253-018-9324-7</ArticleId><ArticleId IdType="pmc">PMC7080177</ArticleId><ArticleId IdType="pubmed">30143837</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokuhara D., Álvarez B., Mejima M., Hiroiwa T., Takahashi Y., Kurokawa S., Kuroda M., Oyama M., Kozuka-Hata H., Nochi T., et al. Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection. J. Clin. Investig. 2013;123:3829–3838. doi: 10.1172/JCI70266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI70266</ArticleId><ArticleId IdType="pmc">PMC3754275</ArticleId><ArticleId IdType="pubmed">23925294</ArticleId></ArticleIdList></Reference><Reference><Citation>Panikar S.S., Banu N., Haramati J., Del Toro-Arreola S., Riera Leal A., Salas P. Nanobodies as efficient drug-carriers: Progress and trends in chemotherapy. J. Control. Release Off. J. Control. Release Soc. 2021;334:389–412. doi: 10.1016/j.jconrel.2021.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jconrel.2021.05.004</ArticleId><ArticleId IdType="pubmed">33964364</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison C. Nanobody approval gives domain antibodies a boost. Nat. Rev. Drug Discov. 2019;18:485–487. doi: 10.1038/d41573-019-00104-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41573-019-00104-w</ArticleId><ArticleId IdType="pubmed">31267082</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrama D., Reisfeld R.A., Becker J.C. Antibody targeted drugs as cancer therapeutics. Nat. Rev. Drug Discov. 2006;5:147–159. doi: 10.1038/nrd1957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd1957</ArticleId><ArticleId IdType="pubmed">16424916</ArticleId></ArticleIdList></Reference><Reference><Citation>Arce L.P., Pavan M.F., Bok M., Gutiérrez S.E., Estein S.M., Santos A.T., Condorí W.E., Uhart M.M., Parreño V., Vizoso-Pinto M.G., et al. A multispecies competitive nanobody-based ELISA for the detection of antibodies against hepatitis E virus. Sci. Rep. 2023;13:15448. doi: 10.1038/s41598-023-41955-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-41955-z</ArticleId><ArticleId IdType="pmc">PMC10507121</ArticleId><ArticleId IdType="pubmed">37723180</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H., Ren J., Wu S., Guo H., Du Y., Wan B., Ji P., Wu Y., Zhuang G., Zhang A., et al. HRP-conjugated-nanobody-based cELISA for rapid and sensitive clinical detection of ASFV antibodies. Appl. Microbiol. Biotechnol. 2022;106:4269–4285. doi: 10.1007/s00253-022-11981-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00253-022-11981-4</ArticleId><ArticleId IdType="pmc">PMC9130055</ArticleId><ArticleId IdType="pubmed">35612629</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W., Yu Y., Xin C., Jin G. Comparative study of optical fiber immunosensors based on traditional antibody or nanobody for detecting HER2. Talanta. 2024;277:126317. doi: 10.1016/j.talanta.2024.126317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.talanta.2024.126317</ArticleId><ArticleId IdType="pubmed">38810383</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao F., Wang L., Zhao X., Lu T., Na A.M., Wang X., Cao J., Du Y. Preparation and characterization of a single-domain antibody specific for the porcine epidemic diarrhea virus spike protein. AMB Express. 2019;9:104. doi: 10.1186/s13568-019-0834-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13568-019-0834-1</ArticleId><ArticleId IdType="pmc">PMC6626092</ArticleId><ArticleId IdType="pubmed">31300902</ArticleId></ArticleIdList></Reference><Reference><Citation>Marblestone J.G., Edavettal S.C., Lim Y., Lim P., Zuo X., Butt T.R. Comparison of SUMO fusion technology with traditional gene fusion systems: Enhanced expression and solubility with SUMO. Protein Sci. 2006;15:182–189. doi: 10.1110/ps.051812706.</Citation><ArticleIdList><ArticleId IdType="doi">10.1110/ps.051812706</ArticleId><ArticleId IdType="pmc">PMC2242369</ArticleId><ArticleId IdType="pubmed">16322573</ArticleId></ArticleIdList></Reference><Reference><Citation>Bird L.E. High throughput construction and small scale expression screening of multi-tag vectors in Escherichia coli. Methods. 2011;55:29–37. doi: 10.1016/j.ymeth.2011.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2011.08.002</ArticleId><ArticleId IdType="pubmed">21856427</ArticleId></ArticleIdList></Reference><Reference><Citation>Singhvi P., Panda A.K. Solubilization and Refolding of Inclusion Body Proteins. Methods Mol. Biol. 2022;2406:371–387. doi: 10.1007/978-1-0716-1859-2_22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-0716-1859-2_22</ArticleId><ArticleId IdType="pubmed">35089569</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S.M., Sharma A., Upadhyay A.K., Singh A., Garg L.C., Panda A.K. Solubilization of inclusion body proteins using n-propanol and its refolding into bioactive form. Protein Expr. Purif. 2012;81:75–82. doi: 10.1016/j.pep.2011.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pep.2011.09.004</ArticleId><ArticleId IdType="pubmed">21964443</ArticleId></ArticleIdList></Reference><Reference><Citation>Berryman M.A., Triplett E.W., Ludvigsson J. Human leukocyte antigen-dependent colonization of Lactobacillus in the early-life gut. Front. Microbiomes. 2023;2:1192773. doi: 10.3389/frmbi.2023.1192773.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/frmbi.2023.1192773</ArticleId></ArticleIdList></Reference><Reference><Citation>Pusch O., Boden D., Hannify S., Lee F., Tucker L.D., Boyd M.R., Wells J.M., Ramratnam B. Bioengineering lactic acid bacteria to secrete the HIV-1 virucide cyanovirin. J. Acquir. Immune Defic. Syndr. 2005;40:512–520. doi: 10.1097/01.qai.0000187446.76579.d3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.qai.0000187446.76579.d3</ArticleId><ArticleId IdType="pubmed">16284525</ArticleId></ArticleIdList></Reference><Reference><Citation>Giomarelli B., Provvedi R., Meacci F., Maggi T., Medaglini D., Pozzi G., Mori T., McMahon J.B., Gardella R., Boyd M.R. The microbicide cyanovirin-N expressed on the surface of commensal bacterium Streptococcus gordonii captures HIV-1. AIDS. 2002;16:1351–1356. doi: 10.1097/00002030-200207050-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002030-200207050-00006</ArticleId><ArticleId IdType="pubmed">12131211</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>